Silver Book Fact

277 medicines are currently in development to treat or prevent heart disease and stroke.

PhRMA. 2008 Report: Medicines in Development for Older Americans; November 2008

Reference

Title
2008 Report: Medicines in Development for Older Americans
Publication Date
November 2008
Authors
PhRMA

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Because of reduced mortality rates, the number of stroke survivors who are non-institutionalized increased from 2.0 to 2.4 million between 1980 and 1991.  
  • Satisfaction rates of heart valve disease patients with their treatment
     
  • Cost of warfarin therapy for AFib patients
    In patients with nonvalvular atrial fibrillation (AF) and one additional stroke risk factor, warfarin therapy cost $8,000 per quality-adjusted life-year (QALY) saved.  
  • 277 medicines are currently in development to treat or prevent heart disease and stroke.  
  • New approaches are under development to reduce ischemic stroke damage and other damage occuring because of stroke.